| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.5M | +56.9% |
| Cost of Revenue | $1.0M | +13.9% |
| Gross Profit | $413K | +2394.4% |
| R&D Expense | $9.3M | +27.3% |
| SG&A Expense | $11.2M | -48.9% |
| Operating Income | -$25.1M | -39.7% |
| Pre-tax Income | -$24.9M | -33.5% |
| Net Income | -$27.8M | +61.9% |
| EPS (Basic) | -$3.75 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.4M | -52.8% |
| Accounts Receivable | $484K | -75.9% |
| Current Assets | $10.7M | -58.1% |
| Total Assets | $74.9M | -25.2% |
| Current Liabilities | $7.2M | -40.6% |
| Total Liabilities | $49.3M | -18.5% |
| Stockholders' Equity | $20.5M | -40.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.3M | +48.8% |
| Capital Expenditures | $281K | -93.5% |
| Investing Cash Flow | -$932K | +78.5% |
| Financing Cash Flow | $12.2M | -66.0% |
| Free Cash Flow | -$23.6M | +52.7% |
| -468.2% |
| EPS (Diluted) | -$3.75 | +71.7% |